| 1241 |
|
Product and service delivery satisfaction among North American cruise passengers
|
Teye, V. B
|
Butterworths
|
1998
|
|
|
|
| 1242 |
|
Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
|
Claassen, I
|
Butterworths
|
1996
|
|
|
|
| 1243 |
|
Production of a genetically engineered inhibin vaccine
|
Geary, T. W
|
Butterworths
|
1996
|
|
|
|
| 1244 |
|
Production of interferon induced by Streptococcus thermophilus: role of CD4^+ and CD8^+ lymphocytes
|
Aattouri, N
|
Butterworths
|
1980
|
|
|
|
| 1245 |
|
Progress and achievement of rabies control in Thailand
|
Wasi, C
|
Butterworths
|
1997
|
|
|
|
| 1246 |
|
Progress in plant breeding
농학도서관 대출가능
|
Russell, G. E
|
Butterworths
|
1985-
|
|
|
|
| 1247 |
|
Project planning in a virtual world: information management metamorphosis or technology going too
|
Gardiner, P. D
|
Butterworths
|
1999
|
|
|
|
| 1248 |
|
Promotional competitions: a winning tool for tourism marketing
|
Peattie, K
|
Butterworths
|
1996
|
|
|
|
| 1249 |
|
Prophylactic and therapeutic effects of n-3 polyunsaturated fatty acids,capsaicin, and curcumin on adjuvant induced arthritis in rats
|
Joe, B
|
Butterworths
|
1980
|
|
|
|
| 1250 |
|
Prophylaxis of experimental HTLV-1 infection in cynomolgus monkeys by passive immunization
|
Suzuki, T. Hoshino, H. Akari, H. Ikeda, K.
|
Butterworths
|
1997
|
|
|
|
| 1251 |
|
Prospects for the use of new vaccines in developing countries: cost is not the only impediment
|
Hausdorff, W. P
|
Butterworths
|
1996
|
|
|
|
| 1252 |
|
Protecting women who provide security for a husband's, partner's or child's debts. The value and limits of an economic perspective
|
Richardson, M
|
Butterworths
|
1996
|
|
|
|
| 1253 |
|
Protection against Helicobacter pylori infection in mice by intragastricvaccination with H. pylori antigens is achieved using a non-toxic mutantof E. coli heat-labile enterotoxin (LT) as adjuvant
|
Marchetti, M
|
Butterworths
|
1998
|
|
|
|
| 1254 |
|
Protection against influenza virus challenge by topical application of influenza DNA vaccine/
|
Watabe, Setsuko
|
Butterworths
|
2001
|
|
|
|
| 1255 |
|
Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin/
|
Watanabe, I
|
Butterworths
|
2003
|
|
|
|
| 1256 |
|
Protection against measles virus-induced encephalitis by antibodies frommice immunized intranasally with a synthetic peptide immunogen
|
Hathaway, L. J
|
Butterworths
|
1998
|
|
|
|
| 1257 |
|
Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen
|
Hormaeche, C. E
|
Butterworths
|
1996
|
|
|
|
| 1258 |
|
Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain
|
Hota-Mitchell, S
|
Butterworths
|
1997
|
|
|
|
| 1259 |
|
Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes/
|
Shalaby, K. A
|
Butterworths
|
2003
|
|
|
|
| 1260 |
|
Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C
|
Macpherson, A. M. Norton, P. M. Wells, J. M. Brown, H. W. G.
|
Butterworths
|
1997
|
|
|
|